| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Executive Officer | Director | Chief Operating Officer +2 more
2 companies
Klein Matthew B. is a Chief Executive Officer at PTC THERAPEUTICS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 7 sells.
Estimated insider holdings value: $32.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr 20, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Development Officer | Sell | 2,500 | $47.23 | $118,080.76 | -4.6% | -9.5% | -7.7% | |
| Jan 15, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Development Officer | Sale+OE | 4,300 | $69.09 | $297,078.40 | -18.2% | - | - | |
| Jan 8, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Development Officer | Sale+OE | 5,500 | $69.71 | $383,410.00 | -12.1% | - | - | |
| Jan 7, 2021 | PTCT Ptc Therapeutics, Inc. | Chief Development Officer | Sale+OE | 3,886 | $68.98 | $268,056.28 | -16.8% | - | - |